Embed Size (px)
Citation preview
Alex Delgado, VP BD & Exports,
Italfarmaco Group
Anil Okay, VP of Business DevelopmentAlvogen/Alvotech/ Commercial Head of Alvotech
W W W . P H A R M A - S Y N E R G Y - C O N F E R E N C E . C O M
Tel: +44(0)20 3884 3055
email: [email protected]
P H A R M A S Y N E R G Y C O N F E R E N C E &
B D & L P A R T N E R I N G M E E T I N G S
24-25 February 2020 London
DISCUSS GLOBAL BUSINESS DEVELOPMENT OPPORTUNITIES WITH YOUR PEERS:
Organised by:
Marco Cerato, Senior VP BD & StrategicPartnerships, Mundipharma
Sara Limam Masmoudi,CEOKilani Group
Ghandi Yacoub, Senior VP Middle East Region,Tabuk Pharmaceuticals
Cengiz Zaim, Commercial Director B2B,Sandoz
Juliana Mazza Reis,Director of BD & Licensing,Eurofarma
Csaba Pipei,Head of M&A -BDEgis Pharmaceuticals
www.pharma-synergy-conference.com
Stephani Saverio, Head of Innovation & BD,
Aché
Nic Talbot-Watt, CEOBlack Swan Analysis
Louis Boon, CSOBioceros
Bahaa Rashad, BD DirectorSAJA Pharmaceuticals
Erika Geimonen, VP of BD Amring Pharmaceuticals
Vladimir Khristenko, President Nanolek
Carlos Grzelak, Latin America GeneralManagerEmcure Pharmaceuticals
Thomas Rudolph, Senior Partner, McKinsey & Co
Patricia Ferriot, International & BusinessDevelopment Director, Salvat
Jose Ignacio Diaz, Head of CommercialOperations Emergpharma
Kuntal Chatterjee,BD International Division,Berlin-Chemie AG
Haleh Hamedifar,Co-Founder, Singapore Biotech
Gaurav Jain,Head, Corporate Licensing &Alliance, Adare Pharmaceuticals
Andreas Loizou,Group BusinessDevelopment Director,Medochemie
W W W . P H A R M A - S Y N E R G Y - C O N F E R E N C E . C O MTel: +44(0)20 3884 3055
email: [email protected]
P H A R M A S Y N E R G Y C O N F E R E N C E &
B D & L P A R T N E R I N G M E E T I N G S
24-25 February 2020 London
PHARMA SYNERGY IN FACTS & FIGURES:
By region: By job title:By productivity:
12 hours of 1-2-1 meetings
Each 1-2-1 meeting is pre-planned & based on detailedprofile information suppliedin advance
Global outreach: participants come from 25+ countries
Media partners:
Sponsored by:
W W W . P H A R M A - S Y N E R G Y - C O N F E R E N C E . C O M
24-25 February 2020 London
JUST SOME OF THE COMPANIES THAT ARE TAKING PART IN 2020:
P H A R M A S Y N E R G Y C O N F E R E N C E &
B D & L P A R T N E R I N G M E E T I N G S
W W W . P H A R M A - S Y N E R G Y - C O N F E R E N C E . C O MTel: +44(0)20 3884 3055
email: [email protected]
8.00 - 08.30 Registration & Coffee8.35 Opening presentation by Lynx2Market 8.35 - 09.30 Session 1: INTERNATIONALIZATION & GROWTH STRATEGIES• Creating the model that is right for your products, markets and the company. Local market entries: direct launches vs alliances – understanding the margins factor interplay. • Cross-border product portfolio adaptation; Practical examples of developing a pipeline• Mid-cap successful internationalization strategies: consideration factors and key prep-stepso Case study: Transforming a branded business into a highly focused speciality businesso Case study: Growth in branded markets via differentiated formulations and service NEW! 09.30 - 10.30 VALUE-CREATING STRATEGIES• Valuing Assets in healthcare• Creating value through asset (product and product portfolio) deals• Innovation and Value Capture Strategies 10.30 - 10.40 Break Discussion 10.40 - 11.40 COMMERCIAL ALLIANCES & LICENSING DEALS • Partner selection in strategic alliances: key approaches and strategies• Practical examples of developing a pipeline via partnerships• Alignment between international & local companies – where do partnerships fail?• Partnering with innovators to market authorised generics – what are the opportunities? 11.40 - 12.40 Spotlight on Biosimilars• Overview of the key markets dynamics, drivers & limitations: tender vs retail• Business Development models for biosimilars across growth regions: considerations and trends in co-partnering vs integration• Opportunities for pursuing the lower-cost approach of an in-licensing without cost-intensive development 12.40 - 13.30 Lunch
13.30 - 19.00 Pre-arranged 1-2-1 PARTNERING MEETINGSDiscuss licensing, investment and partnership opportunities together with regional and international
pharmaceutical players. Use the event’s online platform to present your company and to explain which areayou are looking for. All meetings are pre-arranged and booked in advance.
19.00 - 21.00 Cocktail Reception
Day One, February 24, 2020
W W W . P H A R M A - S Y N E R G Y - C O N F E R E N C E . C O MTel: +44(0)20 3884 3055
email: [email protected]
NEW! 09:30 - 10:00 Spotlight on OTC products: key consideration for portfoliostrategy, product partnerships and long-term market success 10:00 - 11.50 Extended Session: GLOBAL MARKET OPPORTUNITIES The country-focused sections will consider top level and practical information on themarket entries. The session will look at the opportunities for international sales,acquisitions and partnerships. Several countries and regions will be discussed in-depth:SEA, LATAM, Russia & EAEU, MENA Each regional presentation will outline the country-specific factors:• Considering the cost of entry: what could local partners bring to the table? Nationalplayers and “partners of choice” for the markets• Understanding legal, IP, patent related environment • Pricing policies, price baskets in tenders; Existing restrictions for international players• Registration processes including dossier structures for different registration cases,timelines for approvals 11.50 - 12.00 Break NEW! 12.00 - 13.00 QUICK FIRE SESSION: Introduce and position your company as a“Partner of choice”. The 7-minutes presentations will reach a highly targeted audience,providing an opportunity to share valuable information about your portfolio andlicensing capabilities before the meetings 13.00 - 14.00 Lunch
14.00 - 19.00 Pre-arranged 1-2-1 PARTNERING MEETINGS
19.00 End of the event
Day Two, February 25, 2020
